Literature DB >> 15655432

Comparison of coding of heart failure and comorbidities in administrative and clinical data for use in outcomes research.

Douglas S Lee1, Linda Donovan, Peter C Austin, Yanyan Gong, Peter P Liu, Jean L Rouleau, Jack V Tu.   

Abstract

BACKGROUND: Despite the potential usefulness of administrative databases for evaluating outcomes, coding of heart failure and associated comorbidities have not been definitively compared with clinical data.
OBJECTIVE: To compare the predictive value of heart failure diagnoses and secondary conditions identified in a large administrative database with chart-based records.
METHODS: The authors studied 1808 patient records sampled from 14 acute care hospitals and compared clinically recorded data with administrative records from the Canadian Institute for Health Information. The impact of comorbidity coding in the administrative data set according to the Charlson classification was examined in models of 30-day mortality.
RESULTS: The positive predictive value (PPV) of a primary diagnosis ICD-9 428 was 94.3% using the Framingham criteria and 88.6% using criteria previously validated with pulmonary capillary wedge pressure. There was reduced prevalence of secondary comorbid conditions in administrative data in comparison with clinical chart data. The specificities and PPV/negative predictive values of administratively identified index comorbidities were high. The sensitivities of index comorbidities were low, but were enhanced by examination of hospitalizations within 1 year prior to the index heart failure admission. Using information from prior hospitalizations modestly enhanced 30-day mortality model performance; however, the odds ratio point estimates of the index and enhanced administrative data sets were consistent with the clinical model.
CONCLUSION: The ICD-9 428 primary diagnosis is highly predictive of heart failure using clinical criteria. Examination of hospitalization data up to 1 year prior to the index admission improves comorbidity detection and may provide enhancements to future studies of heart failure mortality.

Entities:  

Mesh:

Year:  2005        PMID: 15655432     DOI: 10.1097/00005650-200502000-00012

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  139 in total

1.  Risk of heart failure with human immunodeficiency virus in the absence of prior diagnosis of coronary heart disease.

Authors:  Adeel A Butt; Chung-Chou Chang; Lewis Kuller; Matthew Bidwell Goetz; David Leaf; David Rimland; Cynthia L Gibert; Krisann K Oursler; Maria C Rodriguez-Barradas; Joseph Lim; Lewis E Kazis; Stephen Gottlieb; Amy C Justice; Matthew S Freiberg
Journal:  Arch Intern Med       Date:  2011-04-25

Review 2.  A systematic review of validated methods for identifying heart failure using administrative data.

Authors:  Jane S Saczynski; Susan E Andrade; Leslie R Harrold; Jennifer Tjia; Sarah L Cutrona; Katherine S Dodd; Robert J Goldberg; Jerry H Gurwitz
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-01       Impact factor: 2.890

Review 3.  Validation of CKD and related conditions in existing data sets: A systematic review.

Authors:  Morgan E Grams; Laura C Plantinga; Elizabeth Hedgeman; Rajiv Saran; Gary L Myers; Desmond E Williams; Neil R Powe
Journal:  Am J Kidney Dis       Date:  2010-08-06       Impact factor: 8.860

4.  Statins and renovascular disease in the elderly: a population-based cohort study.

Authors:  Daniel G Hackam; Fangyun Wu; Ping Li; Peter C Austin; Sheldon W Tobe; Muhammad M Mamdani; Amit X Garg
Journal:  Eur Heart J       Date:  2010-12-14       Impact factor: 29.983

Review 5.  Administrative data have high variation in validity for recording heart failure.

Authors:  Susan Quach; Claudia Blais; Hude Quan
Journal:  Can J Cardiol       Date:  2010-10       Impact factor: 5.223

6.  Performance of claims-based algorithms for identifying heart failure and cardiomyopathy among patients diagnosed with breast cancer.

Authors:  Larry A Allen; Marianne Ulcickas Yood; Edward H Wagner; Erin J Aiello Bowles; Roy Pardee; Robert Wellman; Laurel Habel; Larissa Nekhlyudov; Robert L Davis; Adedayo A Onitilo; David J Magid
Journal:  Med Care       Date:  2014-05       Impact factor: 2.983

7.  Impact of length of stay after coronary bypass surgery on short-term readmission rate: an instrumental variable analysis.

Authors:  Yue Li; Xueya Cai; Dana B Mukamel; Peter Cram
Journal:  Med Care       Date:  2013-01       Impact factor: 2.983

8.  A population-based study of the drug interaction between proton pump inhibitors and clopidogrel.

Authors:  David N Juurlink; Tara Gomes; Dennis T Ko; Paul E Szmitko; Peter C Austin; Jack V Tu; David A Henry; Alex Kopp; Muhammad M Mamdani
Journal:  CMAJ       Date:  2009-01-28       Impact factor: 8.262

9.  Comparison of administrative/billing data to expected protocol-mandated chemotherapy exposure in children with acute myeloid leukemia: A report from the Children's Oncology Group.

Authors:  Tamara P Miller; Andrea B Troxel; Yimei Li; Yuan-Shung Huang; Todd A Alonzo; Robert B Gerbing; Matt Hall; Kari Torp; Brian T Fisher; Rochelle Bagatell; Alix E Seif; Lillian Sung; Alan Gamis; David Rubin; Selina Luger; Richard Aplenc
Journal:  Pediatr Blood Cancer       Date:  2015-03-11       Impact factor: 3.167

10.  Measuring quality of care in syncope: case definition affects reported electrocardiogram use but does not bias reporting.

Authors:  Jeremiah D Schuur; Amy Justice
Journal:  Acad Emerg Med       Date:  2009-01       Impact factor: 3.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.